Medication info

Chungwoo 50% Dextrose Injection

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›500g / 1000mL
Manufacturer / importer
JW Pharmaceutical Corporation
Appearance
Colorless and transparent solution contained in a multilayer film plastic container
Packaging
50 mL, 100 mL, 500 mL
Approval status
Active

MFDS item code 195600006 · Notified 1956.11.28 · Insurance code 644902282,644902292,644914991

Summary

Main use
Water and energy supplementation (e.g., hypoglycemia); treatment of heart disease and drug and toxic substance poisoning
Who receives it
Adults
Adult administration
○ Adults: Inject 20~500 mL intravenously per dose. ○ The intravenous drip rate should not exceed 0,5 g/kg per hour as glucose. ○ Use an appropriate amount to dissolve and dilute injectable medications. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Corporation

Efficacy & effects

Water and energy supplementation (e.g., hypoglycemia); treatment of heart disease and drug and toxic substance poisoning

  • Hyperkalemia
  • circulatory collapse
  • hypoglycemia
View approved original text

This medication is used to replenish energy in the body during hyperkalemia, circulatory collapse, and hypoglycemia. It also aids in hydration and energy supply needed during the treatment of heart diseases, and is used in cases of poisoning caused by drugs or toxins. The main purpose is to maintain the electrolyte balance in the body and stabilize the patient's condition through energy supply. Therefore, it is effectively utilized in the treatment of hyperkalemia, heart diseases, and poisoning.

How it is given

Adult administration

○ Adults: Inject 20~500 mL intravenously per dose. ○ The intravenous drip rate should not exceed 0,5 g/kg per hour as glucose. ○ Use an appropriate amount to dissolve and dilute injectable medications. Adjust the dose as appropriate according to age and symptoms.

Precautions

Caution should be exercised when cutting this medication as glass fragments may enter when using the ampoule injection, especially when administered to children or the elderly. The glucose included in this medication may increase the consumption of thiamine (Vitamin B₁) during intravenous administration, potentially leading to fatal deficiency, so caution is necessary. This medication should not be administered to patients with storage dehydration, excessive fluids, hyperglycemia, acidosis, hypokalemia, hyperosmolar coma, glucose intolerance, anuria, or hepatic coma. Additionally, this medication in hypertonic form should not be used in patients with spinal cord hemorrhage or intracranial hemorrhage, and caution should be taken in severely dehydrated patients as it may worsen hyperosmolar conditions. In patients with a tendency for potassium, phosphate, or magnesium deficiency, or those with hyponatremia, diabetes insipidus, renal failure, heart failure, severe malnutrition, thiamine deficiency, sepsis, severe trauma, shock, chronic uremia, or diabetes, it should be administered cautiously. Rapid administration of this medication in large quantities can lead to electrolyte loss, and exceeding the recommended dose may increase bilirubin and lactate levels, necessitating caution. Adverse reactions may include hypokalemia, hypertonic coma, acidosis, dehydration, hyperosmolarity, polyuria, fluid overload, congestion, pulmonary edema, phlebitis, thrombosis, and local pain at the injection site. Prolonged administration may affect insulin production, so insulin should be given together if necessary, and blood glucose and electrolyte levels should be regularly monitored while considering fluid balance. During pregnancy, the potential risk to the fetus necessitates use only when the therapeutic benefits outweigh the risks, and administration during labor may lead to hyperglycemia and hypoglycemia in both the mother and newborn, requiring careful judgment. In children and newborns, their fluid and electrolyte regulation capabilities are immature, so blood glucose and electrolyte levels should be closely monitored, particularly in preterm or low-birth-weight infants as the risk of intracranial hemorrhage may increase. Elderly patients may have reduced body function, so administration should be done with extra caution. Overdosage may lead to hyperglycemia and diabetes, which may necessitate insulin administration. Subcutaneous injections may cause circulatory failure due to electrolyte shifts in plasma and should be avoided due to significant local irritation; any remaining medication after opening should be disposed of immediately. When administering injections, precautions against infection should be taken, and the solution should be warmed to body temperature during cold weather. A sudden stop after administering concentrated solutions may cause hypoglycemia, so gradual adjustments are required, and interactions and adverse reaction possibilities should be thoroughly considered when administering with other medications. To prevent air embolism, avoid injecting air into the container and refrain from continuous connected administration.

Side effects

  • Electrolyte loss
  • elevated bilirubin levels
  • elevated lactate levels
  • hypokalemia
  • hyperosmolar coma
  • acidosis
  • dehydration
  • hyperosmolarity
  • polyuria
  • fluid or solute overload
Show 11 more
  • fluid-electrolyte imbalance
  • congestion
  • pulmonary edema
  • hyperglycemia
  • renal loss
  • fever
  • thrombophlebitis
  • thrombosis
  • leakage of blood
  • injection site pain
  • uremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. This will help maintain the efficacy of the medication and prevent deterioration.

Appearance and packaging

Appearance

Colorless and transparent solution contained in a multilayer film plastic container

Package unit

50 mL, 100 mL, 500 mL

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.